NDC 0006-4045 – Gardasil
Human Papillomavirus Type 6 L1 Capsid Protein Antigen 20 ug/.5mL; Human Papillomavirus Type 11 L1 Capsid Protein Antigen 40 ug/.5mL; Human Papillomavirus Type… · Injection, Suspension · Intramuscular
Product NDC0006-4045
Product details
- Brand name
- Gardasil
- Generic name
- Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Marketing category
- BLA · BLA125126
- Marketed since
- June 8, 2006
- Listing expires
- December 31, 2026
- Pharmacologic class
- Inactivated Human Papillomavirus Vaccine; Inactivated Human Papillomavirus Vaccine; Inactivated Human Papillomavirus Vaccine; Inactivated Human Papillomavirus Vaccine
Active ingredients
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0006-4045-00 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4045-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4045-01) | Jun 8, 2006 |
| 0006-4045-41 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4045-41) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4045-01) | Jun 8, 2006 |
Other Gardasil products
- 0006-4109 Human Papillomavirus Type 6 L1 Capsid Protein Antigen 20 ug/.5mL;… · Injection, Suspension · Merck Sharp & Dohme LLC